NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

Abstract Background NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants ar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Misya’il Abdul Rashid, Mohamad Syafeeq Faeez Md Noh, Abdul Hanif Khan Yusof Khan, Wei Chao Loh, Janudin Baharin, Azliza Ibrahim, Liyana Najwa Inche Mat, Wan Aliaa Wan Sulaiman, Fan Kee Hoo, Fazah Akhtar Hanapiah, Hamidon Basri
Formato: article
Lenguaje:EN
Publicado: SpringerOpen 2021
Materias:
Stroke
Chinese traditional medication
Hepatotoxicity
NeuroAid II
Elderly
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Acceso en línea:https://doaj.org/article/8e2912eb01e540368284ee5b4ff77d01
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/8e2912eb01e540368284ee5b4ff77d01

Ejemplares similares